Articles with public access mandates - Jing WangLearn more
Not available anywhere: 3
Review
Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants
Kalu NN, Mazumdar T, Peng S, Tong P, Shen L, Wang J, Banerjee U, Myers JN ...
Cancer Lett., 2018
Mandates: US National Institutes of Health
Review
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stress
Valenzuela N, Soibam B, Li L, Wang J, Byers LA, Liu Y, Schwartz RJ, Stewart MD
J Cell Sci, 2017
Mandates: American Heart Association
Review
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection
Le X, Gleber-Netto FO, Rubin ML.
Clin Cancer Res., 2022
Mandates: US National Institutes of Health
Available somewhere: 223
Review
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Mandates: US Department of Defense, US National Institutes of Health
Review
Comprehensive genomic characterization of head and neck squamous cell carcinomas
TCGA Network
Nature, 2015
Mandates: US National Institutes of Health
Review
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Mandates: US National Institutes of Health
Review
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Mandates: US National Institutes of Health
Review
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
Mandates: US National Institutes of Health
Review
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ...
Science 333 (6046), 1154-1157, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Review
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Review
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Skoulidis F, et al
Cancer Discov, 2018
Mandates: US National Institutes of Health, V Foundation, USA
Review
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAS, Andrews MC, Sharma P, Wang ...
Cell, 2017
Mandates: US National Institutes of Health
Review
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
Mandates: US National Institutes of Health
Review
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
Mandates: US National Institutes of Health
Review
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
CGAR Network
Cell, 2017
Mandates: US National Institutes of Health
Review
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, Izzo, ...
Cancer Discovery 5, 860-77, 2015
Mandates: US National Institutes of Health, V Foundation, USA
Review
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
Mandates: US National Institutes of Health
Review
Targeting DNA damage response promotes anti-tumor immunity through STING-mediated T-cell activation in small cell lung cancer
Sen T, Rodriguez BL, Chen L, Della Corte C, Morikawa N, Fujimoto J, Cristea ...
Cancer Discovery, 2019
Mandates: US National Institutes of Health
Review
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
DL Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess ...
Cell Syst, 2018
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program